EUVIMEDEUVIMED entdecken
Crossref

Life‐course adiposity and severe liver disease: a Mendelian randomization analysis

Xinyu Wang, Zhiyu Wu, Jun Lv, Canqing Yu iD, Dianjianyi Sun, Pei Pei, Ling Yang, Iona Y Millwood, Robin Walters, Yiping Chen, Huaidong Du, Mingqiang Yuan und 7 weitere

Obesity · 2023

DOI: 10.1002/oby.23913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity, 2023. Verfasst von Xinyu Wang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Pediatric Obesity, Liver Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, UK Wellcome Trust, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

There is little evidence on the genetic associations between life‐course adiposity (including birth weight, childhood BMI, and adulthood BMI) and severe liver disease (SLD; including cirrhosis and liver cancer). The current study aimed to examine and contrast these associations.

Methods

Genetic variants were obtained from genome‐wide association studies. Two‐sample Mendelian randomization (MR) analyses were performed to assess the genetic associations of life‐course adiposity with SLD and liver biomarkers. Cox regression was used to estimate adjusted hazard ratios for SLD associated with genetic risk scores of life‐course adiposity and adulthood weight change in the China Kadoorie Biobank.

Results

In observational analyses, genetic predispositions to childhood adiposity and adulthood adiposity were each associated with SLD. There was a U‐shaped association between adulthood weight change and risk of SLD. In meta‐analyses of MR results, genetically predicted 1‐standard deviation increase in birth weight was inversely associated with SLD at a marginal significance (odds ratio: 0.81 [95% CI: 0.65–1.00]), whereas genetically predicted 1‐standard deviation higher childhood BMI and adulthood BMI were positively associated with SLD (odds ratio: 1.27 [95% CI: 1.05–1.55] and 1.79 [95% CI: 1.59–2.01], respectively). The results of liver biomarkers mirrored those of SLD.

Conclusions

The current study provided genetic evidence on the associations between life‐course adiposity and SLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pediatric ObesityLiver DiseasesHumansChildAdiposityMendelian Randomization AnalysisGenome-Wide Association StudyBirth WeightBody Mass IndexBiomarkersPolymorphism, Single Nucleotide

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
  • Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.
  • Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China.
  • Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK.
  • Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Pengzhou Center for Disease Control and Prevention, Pengzhou, China.

ORCID-Profile: Canqing Yu, Yuanjie Pang

Förderung

  • National Natural Science Foundation of China
  • UK Wellcome Trust
  • China Postdoctoral Science Foundation
  • National Key Research and Development Program of China
  • Ministry of Science and Technology of the People's Republic of China
  • Peking University Medicine Fund of Fostering Young Scholars' Scientific & Technological Innovation
  • Cancer Research UK
  • Medical Research Council

Zitieren

APA

Wang, X., Wu, Z., Lv, J., Yu, C., Sun, D., Pei, P., Yang, L., Millwood, I. Y., Walters, R., Chen, Y., Du, H., Yuan, M., Schmidt, D., Barnard, M., Chen, J., Chen, Z., Li, L., Pang, Y., & China Kadoorie Biobank Collaborative Group (2023). Life‐course adiposity and severe liver disease: a Mendelian randomization analysis. Obesity. https://doi.org/10.1002/oby.23913

Vancouver

Wang X, Wu Z, Lv J, Yu C, Sun D, Pei P, et al. Life‐course adiposity and severe liver disease: a Mendelian randomization analysis. Obesity. 2023. doi:10.1002/oby.23913

BibTeX
@article{Wang2023,
  author = {Wang, Xinyu and Wu, Zhiyu and Lv, Jun and Yu, Canqing and Sun, Dianjianyi and Pei, Pei and Yang, Ling and Millwood, Iona Y and Walters, Robin and Chen, Yiping and Du, Huaidong and Yuan, Mingqiang and Schmidt, Dan and Barnard, Maxim and Chen, Junshi and Chen, Zhengming and Li, Liming and Pang, Yuanjie and China Kadoorie Biobank Collaborative Group, China Kadoorie Biobank Collaborative Group},
  title = {Life‐course adiposity and severe liver disease: a Mendelian randomization analysis},
  journal = {Obesity},
  year = {2023},
  doi = {10.1002/oby.23913}
}
Kostenlos starten →